David Domzalski

2022

In 2022, David Domzalski earned a total compensation of $1.3M as President and Chief Executive Officer at VYNE Therapeutics, a 73% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$325,156
Option Awards$128,044
Salary$637,560
Stock Awards$190,504
Other$12,200
Total$1,293,464

Domzalski received $637.6K in salary, accounting for 49% of the total pay in 2022.

Domzalski also received $325.2K in non-equity incentive plan, $128K in option awards, $190.5K in stock awards and $12.2K in other compensation.

Rankings

In 2022, David Domzalski's compensation ranked 2,531st out of 5,736 executives tracked by ExecPay. In other words, Domzalski earned more than 55.9% of executives.

ClassificationRankingPercentile
All
2,531
out of 5,736
56th
Division
Manufacturing
1,398
out of 3,125
55th
Major group
Chemicals And Allied Products
635
out of 1,416
55th
Industry group
Drugs
589
out of 1,317
55th
Industry
Pharmaceutical Preparations
422
out of 963
56th
Source: SEC filing on November 13, 2023.

Domzalski's colleagues

We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2022.

2022

Mutya Harsch

VYNE Therapeutics

Chief Legal Officer

2022

Iain Stuart

VYNE Therapeutics

Chief Scientific Officer

News

You may also like